USP20–RAB8A signaling axis restricts pancreatic cancer progression by disrupting GLUT1 vesicular trafficking and inhibiting glucose uptake
Cancer Letters · 2026-04 · 642 · 218299
DOI: 10.1016/j.canlet.2026.218299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-04. Verfasst von Yu Bai und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 4…. Hauptthemen laut MEDLINE: rab GTP-Binding Proteins, Pancreatic Neoplasms, Glucose Transporter Type 1, Glucose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Hebei Provincial Key Research Projects.
Abstract (Originalsprache)
Cancer cells undergo metabolic reprogramming to meet the demands of rapid proliferation, survival and chemotherapy resistance. Targeting cancer-specific metabolic vulnerabilities offers a compelling strategy for therapeutic intervention. Owing to the Warburg effect and the unique tumor microenvironment, pancreatic ductal adenocarcinoma (PDAC) cells exhibit a high demand for glucose to sustain their energy metabolism. Here, we identify a novel regulatory mechanism controlling the cell surface abundance of glucose transporter 1 (GLUT1), mediated by RAB8A-dependent vesicular trafficking. RAB8A, a member of the RAS oncogene family, enhances GLUT1 membrane localization and thereby increases glucose uptake in PDAC cells. Mechanistically, we demonstrate that ubiquitin-specific peptidase 20 (USP20) negatively regulates RAB8A activation by selectively removing K48-linked polyubiquitin chains from its inactive form. Functional assays in vitro and in vivo validate the tumor-suppressive role of the USP20-RAB8A signaling axis. Furthermore, using primary PDAC cells derived from KPC (KrasG12D/+; Trp53 R172Hflox/flox; Pdx1-Cre) mice, we show that dual knockdown of Rab8a and Glut1 markedly attenuates tumor-promoting effects driven by oncogenic Kras and Trp53 loss. Collectively, our findings reveal that the USP20-RAB8A-GLUT1 axis regulates glucose uptake and metabolic reprogramming in PDAC, thereby inhibiting tumor growth and metastasis. Targeting this signaling axis provides a novel insight into metabolic therapy for pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
- Division of Endocrinology, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
- Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. Electronic address: zhaochunle@hust.edu.cn.
- Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China; State Key Lab of Molecular Oncology & Department of Panc…
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China; Anhui Provincial Key Labora…
- Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China. Electronic address: zfjch1977@163.com.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Hebei Provincial Key Research Projects
Zitieren
APA
Bai, Y., Liu, Z., Zhai, X., Zhang, D., Liu, S., Xia, Q., Chen, L., Shi, Y., Liao, Y., Liu, Y., Zhang, Z., Xu, S., Gong, J., Zhao, C., Wang, M., Shi, X., Zhu, F., & Qin, R. (2026). USP20–RAB8A signaling axis restricts pancreatic cancer progression by disrupting GLUT1 vesicular trafficking and inhibiting glucose uptake. Cancer Letters, 642, 218299. https://doi.org/10.1016/j.canlet.2026.218299
Vancouver
Bai Y, Liu Z, Zhai X, Zhang D, Liu S, Xia Q, et al. USP20–RAB8A signaling axis restricts pancreatic cancer progression by disrupting GLUT1 vesicular trafficking and inhibiting glucose uptake. Cancer Letters. 2026;642:218299. doi:10.1016/j.canlet.2026.218299
BibTeX
@article{Bai2026,
author = {Bai, Yu and Liu, Zixi and Zhai, Xiao and Zhang, Di and Liu, Shiqiang and Xia, Qilong and Chen, Lin and Shi, Yongkang and Liao, Yangwei and Liu, Yuhui and Zhang, Zhenxiong and Xu, Simiao and Gong, Jun and Zhao, Chunle and Wang, Min and Shi, Xiuhui and Zhu, Feng and Qin, Renyi},
title = {USP20–RAB8A signaling axis restricts pancreatic cancer progression by disrupting GLUT1 vesicular trafficking and inhibiting glucose uptake},
journal = {Cancer Letters},
year = {2026},
volume = {642},
pages = {218299},
doi = {10.1016/j.canlet.2026.218299}
}
EUVIMED